Biology of Reproduction, Vol 45, 43-48, Copyright © 1991 by Society for the Study of Reproduction

ARTICLES

Regulation of placental low-density lipoprotein uptake in baboons by estrogen: dose-dependent effects of the anti-estrogen ethamoxytriphetol (MER-25)

MC Henson, GJ Pepe and ED Albrecht
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201.

In the present study, increasing amounts of the anti-estrogen 1-(p-2- diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenoletha nol (MER-25) were administered to pregnant baboons (Papio anubis) to block the action of endogenous estrogen and to determine effect on placental low- density lipoprotein (LDL) uptake. Pregnant baboons were untreated (n = 8) or received MER-25 orally at a dosage of 25 (n = 10), 50 (n = 8), or 75 (n = 4) mg/kg BW daily on Days 140-170 of gestation (term = 184 days). Placentas were removed on Day 170 of gestation and villous tissue was dispersed with 0.1% collagenase. Placental cells (10(6] were incubated in Medium 199 for 12 h at 37 degrees C with increasing amounts of 125I-LDL, with or without a 100-fold excess of unlabeled baboon LDL. Mean (+/- SEM) placental uptake (ng/micrograms cell protein) of 125I-LDL was 55% (6.4 +/- 1.0), 75% (3.6 +/- 0.7), and 81% (2.7 +/- 0.2) lower (p less than 0.001) in baboons that received MER-25 in doses of 25, 50, and 75 mg/kg BW, respectively, than in untreated baboons (14.2 +/- 1.3 ng/micrograms cell protein). Maximal effect occurred with 50 mg MER-25, because LDL uptake was not further decreased with greater levels of MER-25. Dissociation constants for placental LDL uptake, as determined by Scatchard analysis, were unaltered by anti-estrogen treatment. The amount of 125I-LDL degradation by placental cells of untreated and MER-25-treated baboons was proportional to LDL uptake.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				B. Musicki, G. J. Pepe, and E. D. Albrecht Functional Differentiation of the Placental Syncytiotrophoblast: Effect of Estrogen on Chorionic Somatomammotropin Expression during Early Primate Pregnancy J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4316 - 4323. [Abstract] [Full Text] [PDF]

				W. Shi, K. F. Swan, S. R. Lear, J. S. O'Neil, S. K. Erickson, and M. C. Henson Regulation of Pathways Determining Cholesterol Availability in the Baboon Placenta with Advancing Gestation Biol Reprod, December 1, 1999; 61(6): 1499 - 1505. [Abstract] [Full Text]

				B. Musicki, G. J. Pepe, and E. D. Albrecht Functional Differentiation of Placental Syncytiotrophoblasts during Baboon Pregnancy: Developmental Expression of Chorionic Somatomammotropin Messenger Ribonucleic Acid and Protein Levels J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4105 - 4110. [Abstract] [Full Text] [PDF]

				M. C. Henson, S. J. Greene, B. C. Reggio, W. Shi, and K. F. Swan Effects of Reduced Maternal Lipoprotein-Cholesterol Availability on Placental Progesterone Biosynthesis in the Baboon Endocrinology, April 1, 1997; 138(4): 1385 - 1391. [Abstract] [Full Text] [PDF]

				J. S. Babischkin, G. J. Pepe, and E. D. Albrecht Estrogen Regulation of Placental P-450 Cholesterol Side-Chain Cleavage Enzyme Messenger Ribonucleic Acid Levels and Activity During Baboon Pregnancy Endocrinology, January 1, 1997; 138(1): 452 - 459. [Abstract] [Full Text] [PDF]